Details of the Drug Formulations

General Information of Drug (ID: DMWSMND)

Drug Name
Cevimeline Drug Info
Synonyms
Evoxac; Saligren; Cevimeline [INN]; Cevimeline hydrochloride; Cevimeline hydrochloride [USAN]; Cevimeline hydrochloride hemihydrate; Cevimeline hydrochloride hydrate; AF 102B; AF102B; Fks 508; AF-102B; Cevimeline (INN); Cevimeline HCl 1/2H2O; Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Cevimeline.HCl; Evoxac (TN); FKS-508; SND-5008; SNI-2011; SNK-508; Saligren (TN); SND 5008, AF-102B, FKS-508; Cis-2-Methylspiro(1,3-oxathiolane-5,3')quinuclidine hydrochloride hydrate (2:2:1); (+-)-cis-2-Methylspiro(1,3-oxathiolane-5,3'-quinuclidine) hydrochloride, hemihydrate; (+/-)-cis-2-methylspiro(1-azabicyclo[2.2.2]octance-3,5'-(1,3)oxathiolane) hydrochloride hemihydrate; (2R,2'R)-2'-methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] dihydrochloride hydrate; (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]; (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] dihydrate hydrochloride; (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] hydrate dihydrochloride; (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] hydrate hydrochloride; 2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine
Indication
Disease Entry ICD 11 Status REF
Sjogren syndrome 4A43.20 Approved [1]
Therapeutic Class
Parasympathomimetics
Cross-matching ID
PubChem CID
83898
CAS Number
107233-08-9
TTD ID
D0Q4CS
INTEDE ID
DR0294
ACDINA ID
D00117

Full List of Drug Formulations Containing This Drug

Cevimeline 30 mg capsule
Company Formulation ID FDA Description
Novel Laboratories F03972 Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c yellow no. 6; Isopropyl alcohol; Magnesium stearate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Hydroxypropyl cellulose (type e); Shellac
West-Ward Pharmaceticals F03970 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Glycerin; Titanium dioxide; Water; Hydroxypropyl cellulose (1200000 mw)
Avera McKennan Hospital F03971 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Glycerin; Titanium dioxide; Water; Hydroxypropyl cellulose (type h)
American Health Packaging F03973 Lactose monohydrate; Magnesium stearate; Hydroxypropyl cellulose (type h)
Ingenus Pharmaceuticals F03974 Lactose monohydrate; Magnesium stearate; Hydroxypropyl cellulose, unspecified
Apotex F03975 Lactose monohydrate; Magnesium stearate
Ranbaxy Pharmaceuticals; Stat Rx USA F03976 Lactose monohydrate; Magnesium stearate; Hydroxypropyl cellulose
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Formulation(s)

References

1 Therapeutic effect of cevimeline on dry eye in patients with Sj gren's syndrome: a randomized, double-blind clinical study. Am J Ophthalmol. 2004 Jul;138(1):6-17.